Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

245.97 +2.78 (+1.15%)
Streaming Delayed Price Updated: 11:58 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday? ↗
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged... 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For February 6, 2025 ↗
 
Via Benzinga
News headline image
Analyst Expectations For IQVIA Hldgs's Future ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About IQVIA Hldgs? ↗
 
Via Benzinga
News headline image
(IQV) - Analyzing IQVIA Hldgs's Short Interest ↗
 
Via Benzinga
News headline image
Peering Into IQVIA Hldgs's Recent Short Interest ↗
 
Via Benzinga
News headline image
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions ↗
IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and solid R&DS bookings fuel confidence. 
Via Benzinga
News headline image
Gapping S&P500 stocks in Thursday's session ↗
Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
News headline image
Wondering what's happening in today's S&P500 pre-market session? ↗
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars
Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year revenue... 
Via StockStory
News headline image
Looking Into IQVIA Hldgs's Recent Short Interest ↗
 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About IQVIA Hldgs? ↗
 
Via Benzinga
News headline image
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For
Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to look for. 
Via StockStory
News headline image
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
From IQVIA
Via Business Wire
News headline image
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
From IQVIA
Via Business Wire
News headline image
A Closer Look at 13 Analyst Recommendations For IQVIA Hldgs ↗
 
Via Benzinga
News headline image
Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier? ↗
Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions. 
Via Benzinga
Topics Artificial Intelligence
News headline image
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
From IQVIA
Via Business Wire
News headline image
Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute
From IQVIA
Via Business Wire
News headline image
Elliott Investment Management Adds To Southwest, Western Digital, Etsy, Match Group; Trims BILL Holdings, Seadrill, BlackLine, NRG Energy In Q3 ↗
Elliott Investment Management was busy in the third quarter. According to a new 13-F filing with the SEC, the activist made several portfolio moves, with multiple new positions focused around travel... 
Via Benzinga
Topics Regulatory Compliance
News headline image
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024
From IQVIA Holdings Inc.
Via Business Wire
News headline image
GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations ↗
RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age group and reducing demand by two-thirds compared to last year. 
Via Benzinga
News headline image
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™
From IQVIA
Via Business Wire
News headline image
Four Stocks To Watch This Week - Tuesday, Oct. 01 ↗
A flat week that was anticipated, one notable event was China's stimulus package announcement, which sent China-related stocks soaring. Most of these stocks surged without prior consolidations/warning... 
Via Talk Markets
News headline image
Is Viking Therapeutics Stock a Buy? ↗
The company is in the spotlight for one of its programs, but it's got others that also have promise. 
Via The Motley Fool
News headline image
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
From IQVIA
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.